glp 1 antagonist drugs Understanding GLP-1 Inhibitors: How They Work and Why They Matter: Princeton Sports and Family Medicine, P.C.: Sports Medicine GLP-1 Receptor Agonist Shortage: Challenges
Description
Funding: This study was funded by a Foundation Scheme grant from the Canadian Institutes of Health Research (FDN-143328)
J., Smits, M
Degradation of the incretin hormone glucagon-like Peptide-1 (GLP-1) by Enterococcus faecalis metalloprotease GelE
Beyond glycemic control, these agents have been investigated for their pleiotropic anti-inflammatory, anti-atherogenic, and cardioprotective effects, addressing unmet needs in non-diabetic populations with obesity and CVD
Their formulations are rooted in cutting-edge microbiome science and designed to support metabolism, gut barrier health, and even cravings while helping to maintain healthy blood sugar* by delivering next-generation, live probiotic strains to the gut
Markovic TP, Proietto J, Dixon JB, Rigas G, Deed G, Hamdorf JM, et al
